Additionally, we have previously showed that the melanoma-derived lysate TRIMEL induces the release of Th1-polarizing and pro-inflammatory cytokines such as IL-6, TNF-α, and IL-12 in therapeutically used monocyte-derived DCs [18,22]. The gene discussed is TNF; the disease is melanoma.